CIK 0001645460 · Non-accelerated filer<br>Smaller reporting company
Cue Biopharma, Inc.
Sign in to watch- Ticker
- CUE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473324577
- Phone
- 617-949-2680
- Business address
- 100 CHESTNUT STREET, SUITE 300, SOMERVILLE, MA, 02143
- Former names
- Imagen Biopharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $389,304
- in 3 filings
Net −$389,304. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 20 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-08-21 | Millar Kerri-Ann CFO | Grant or award · Stock Option (right to buy) | +65,000 | 65,000 | ||
| 2020-08-21 | Millar Kerri-Ann CFO | Grant or award · Restricted Stock Units | +20,000 | 20,000 | ||
| 2020-08-21 | Millar Kerri-Ann CFO | Option exercise · Restricted Stock Units | −6,666 | 13,334 | ||
| 2020-08-05 | Sandercock Colin SVP, General Counsel and Sec | Option exercise | +13,374 | $7.50 | $100K | 30,499 |
| 2020-08-05 | Sandercock Colin SVP, General Counsel and Sec | Sale | −13,374 | $20.00 | $267K | 17,125 |
| 2020-08-05 | Sandercock Colin SVP, General Counsel and Sec | Option exercise · Stock Option (right to buy) | −13,374 | 130,000 | ||
| 2020-08-05 | Sandercock Colin SVP, General Counsel and Sec | Option exercise | +13,274 | $7.50 | $100K | 30,399 |
| 2020-08-05 | Sandercock Colin SVP, General Counsel and Sec | Sale | −13,274 | $20.00 | $265K | 17,125 |
| 2020-08-05 | Sandercock Colin SVP, General Counsel and Sec | Option exercise · Stock Option (right to buy) | −13,274 | 130,100 | ||
| 2020-08-05 | Suri Anish President and CSO | Option exercise | +800 | $6.42 | $5K | 35,358 |
| 2020-08-05 | Suri Anish President and CSO | Sale | −800 | $20.01 | $16K | 34,558 |
| 2020-08-05 | Suri Anish President and CSO | Option exercise · Stock Option (right to buy) | −800 | 145,000 | ||
| 2020-08-04 | Sandercock Colin SVP, General Counsel and Sec | Option exercise | +201 | $7.50 | $2K | 17,326 |
| 2020-08-04 | Sandercock Colin SVP, General Counsel and Sec | Sale | −201 | $20.05 | $4K | 17,125 |
| 2020-08-04 | Sandercock Colin SVP, General Counsel and Sec | Option exercise · Stock Option (right to buy) | −201 | 143,374 | ||
| 2020-08-04 | Suri Anish President and CSO | Option exercise | +400 | $6.42 | $3K | 34,958 |
| 2020-08-04 | Suri Anish President and CSO | Sale | −400 | $20.14 | $8K | 34,558 |
| 2020-08-04 | Suri Anish President and CSO | Option exercise · Stock Option (right to buy) | −400 | 145,800 | ||
| 2020-08-03 | Sandercock Colin SVP, General Counsel and Sec | Option exercise | +6,425 | $7.50 | $48K | 23,550 |
| 2020-08-03 | Sandercock Colin SVP, General Counsel and Sec | Sale | −6,425 | $20.00 | $129K | 17,125 |
Page 12 of 17 · 323 trades